📰 Looking Statement News
Page 69 - Looking Statement News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Looking Statement. Real-time updates on events, politics, business and more.
January 8, 2022
KENILWORTH, N.J.--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its fourth-quarter and full-year 2021 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EST on Thursday, Feb. 3. During the call, company executives wi...
January 8, 2022
07.01.2022 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its fourth-quarter and full-year 2021 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EST on Thursday, Feb. 3. During the call, ...
January 7, 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
January 5, 2022
KENILWORTH, N.J.--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Robert M. Davis, chief executive officer and president, Dr. Dean Y. Li, president, Merck Research Laboratories, are scheduled to virtually participate in the 40th Annual J.P. Morga...
January 5, 2022
Vancouver, British Columbia--(Newsfile Corp. - January 5, 2022) - Kodiak Copper Corp. (TSXV: KDK) (OTCQB: KDKCF) (FSE: 5DD1).Dear Fellow Investor:2021 was another momentous year for Kodiak Copper. We
December 30, 2021
/PRNewswire/ -- Eltek Ltd. (NASDAQ: ELTK), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards,...
December 30, 2021
/PRNewswire/ -- Eltek Ltd. (NASDAQ: ELTK), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards,...
December 27, 2021
27.12.2021 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the combination of KEYTRUDA, Merck’s anti-PD-1 therapy, plus LENVIMA, the ...
December 24, 2021
Molnupiravir was the first oral COVID-19 antiviral medicine to receive authorization on Nov. 4, when the U.K.’s Medicines and Healthcare Products Regulatory Agency granted authorization.
December 24, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation.